Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China flag China · Delayed Price · Currency is CNY
24.85
-0.13 (-0.52%)
May 8, 2026, 3:00 PM CST

SHA:600645 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,4211,4551,5501,5381,5071,497
Other Revenue
--35.8152.0747.837.94
1,4211,4551,5851,5901,5551,535
Revenue Growth (YoY)
-7.59%-8.23%-0.27%2.24%1.27%16.41%
Cost of Revenue
424.22438.8497.75505.02510.29473.84
Gross Profit
997.271,0161,0881,0851,0451,061
Selling, General & Admin
642.95654.87695.33719.77723.4749.78
Research & Development
146.05149.01182.11184.49146.12133.85
Other Operating Expenses
13.0715.7219.3919.1917.5916.54
Operating Expenses
802.07819.6924.48946.57901.67937.05
Operating Income
195.2196.55163.2138.14142.93124.44
Interest Expense
---5.03-5.02-4.02-3.14
Interest & Investment Income
--24.429.5918.2316.21
Earnings From Equity Investments
2.21--14.3-11.85-7.96-
Currency Exchange Gain (Loss)
---3.21.51-2.370.1
Other Non Operating Income (Expenses)
-5.52-5.49-3.221.03-2-1.49
EBT Excluding Unusual Items
191.9191.06161.84153.4144.82136.13
Impairment of Goodwill
------19.72
Gain (Loss) on Sale of Investments
-6.91-7.92-30.03-36.09-0.7579.09
Gain (Loss) on Sale of Assets
6.596.411.33.672.030.51
Asset Writedown
-16.13-15.11-4.68-0.31-0.8-6.26
Other Unusual Items
--7.5211.929.933.2
Pretax Income
175.45174.45135.95132.59155.21222.96
Income Tax Expense
73.3270.9246.5934.0348.5371.75
Earnings From Continuing Operations
102.13103.5389.3598.55106.68151.21
Minority Interest in Earnings
7.9110.3117.96.34.11
Net Income
110.05113.83100.35106.45112.99155.32
Net Income to Common
110.05113.83100.35106.45112.99155.32
Net Income Growth
24.72%13.43%-5.73%-5.78%-27.26%-
Shares Outstanding (Basic)
460455456463471471
Shares Outstanding (Diluted)
460455456463471471
Shares Change (YoY)
-0.36%-0.18%-1.45%-1.69%0.02%0.17%
EPS (Basic)
0.240.250.220.230.240.33
EPS (Diluted)
0.240.250.220.230.240.33
EPS Growth
25.17%13.64%-4.35%-4.17%-27.27%-
Free Cash Flow
248.55264.07217.87210.4162.7193.22
Free Cash Flow Per Share
0.540.580.480.460.350.41
Gross Margin
70.16%69.84%68.61%68.23%67.18%69.14%
Operating Margin
13.73%13.51%10.29%8.69%9.19%8.11%
Profit Margin
7.74%7.82%6.33%6.70%7.27%10.12%
Free Cash Flow Margin
17.48%18.15%13.74%13.23%10.46%12.58%
EBITDA
343.77335.87265.53281.74253.74227.35
EBITDA Margin
24.18%23.09%16.75%17.72%16.32%14.81%
D&A For EBITDA
148.57139.32102.33143.6110.81102.91
EBIT
195.2196.55163.2138.14142.93124.44
EBIT Margin
13.73%13.51%10.29%8.69%9.19%8.11%
Effective Tax Rate
41.79%40.65%34.27%25.67%31.26%32.18%
Revenue as Reported
--1,5851,5901,5551,535
Advertising Expenses
--30.8632.9829.0232.43
Source: S&P Global Market Intelligence. Standard template. Financial Sources.